Aveanna Healthcare Holdings Inc. filed a Form 8-K on August 24, 2026, disclosing the closing of a secondary offering of 15,000,000 shares of common stock at $11.75 per share, sold entirely by existing stockholders with no proceeds to the company.

Key Highlights

  • Secondary offering size: 15,000,000 shares of common stock offered by selling stockholders at a public offering price of $11.75 per share.
  • Overallotment option: Selling stockholders granted the underwriter a 30-day option to purchase up to an additional 2,250,000 shares.
  • No company proceeds: According to the filing, "The Company did not issue or sell any Common Stock in the Secondary Offering and did not receive any proceeds from the Secondary Offering."
  • Selling stockholders: Included affiliates of J.H. Whitney Equity Partners VII, LLC and certain current and former directors and officers of the company.
  • Underwriter: RBC Capital Markets, LLC served as the sole underwriter under an underwriting agreement dated August 20, 2026.
  • Closing date: The Secondary Offering closed on August 24, 2026.

Aveanna Healthcare Secondary Offering: Terms and Selling Parties

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) disclosed in its August 24, 2026 Form 8-K that on August 20, 2026, it entered into an underwriting agreement with certain selling stockholders and RBC Capital Markets, LLC as underwriter. The offering covered 15,000,000 shares of the company's common stock, par value $0.01 per share, priced at $11.75 per share. The transaction is characterized in the filing as a secondary offering, meaning the shares were sold by existing holders rather than newly issued by the company.

According to the filing, the selling stockholders included affiliates of J.H. Whitney Equity Partners VII, LLC as well as certain current and former directors and officers of Aveanna Healthcare Holdings Inc. The selling stockholders also granted RBC Capital Markets, LLC a 30-day option to purchase up to an additional 2,250,000 shares of common stock, a standard overallotment provision. The filing does not specify whether the overallotment option was exercised.

The company reported that it "did not issue or sell any Common Stock in the Secondary Offering and did not receive any proceeds from the Secondary Offering." The underwriting agreement, dated August 20, 2026, is attached to the filing as Exhibit 1.1. A legal opinion from King & Spalding LLP is included as Exhibit 5.1. The filing was signed by Matthew Buckhalter, Chief Financial Officer, in his capacity as Principal Financial Officer.

What Was Disclosed

Aveanna Healthcare Holdings Inc. reported the closing of a 15,000,000-share secondary stock offering at $11.75 per share, sold by existing stockholders. The company issued no new shares and received no proceeds. The underwriter held a 30-day option for up to 2,250,000 additional shares.